$2.565
-0.835[-24.56%]
Last update: 3:36PM Get Real Time Here
Mersana Therapeutics
(NASDAQ:MRSN)Mersana Therapeutics Stock (NASDAQ:MRSN), Quotes and News Summary
Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
| Open | $3.490 |
| Close | - |
| Volume / Avg. | 2.724M / 2.180M |
| Day Range | 2.560 - 3.500 |
| 52 Wk Range | 0.801 - 9.620 |
| Market Cap | $313.857M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 27 |
| Short Interest | 11.38% |
| Days to Cover | 7.03 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mersana Therapeutics (MRSN) stock?
You can purchase shares of Mersana Therapeutics (NASDAQ: MRSN) through any online brokerage.
Who are Mersana Therapeutics's (MRSN) competitors?
Other companies in Mersana Therapeutics’s space includes: PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE), Anika Therapeutics (NASDAQ:ANIK) and TScan Therapeutics (NASDAQ:TCRX).
What is the target price for Mersana Therapeutics (MRSN) stock?
The latest price target for Mersana Therapeutics (NASDAQ: MRSN) was reported by JP Morgan on Tuesday, March 19, 2024. The analyst firm set a price target for 5.00 expecting MRSN to rise to within 12 months (a possible 94.93% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Mersana Therapeutics (MRSN)?
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $2.565 last updated Today at May 9, 2024 at 3:36 PM EDT.
Does Mersana Therapeutics (MRSN) pay a dividend?
There are no upcoming dividends for Mersana Therapeutics.
When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?
Mersana Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Mersana Therapeutics (MRSN) going to split?
There is no upcoming split for Mersana Therapeutics.
What sector and industry does Mersana Therapeutics (MRSN) operate in?
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.